ADORA2A and metabolic dysfunction-associated steatohepatitis: Furthermore, the study by Alchera E et al. demonstrated that A2AR stimulation inhibited NASH development through inhibiting IL-17-induced JNK-dependent lipotoxicity and Th17 cell expansion [127].